Congratulations to the project team for winning the HSJ Award for ‘Best Pharmaceutical Partnership with the NHS.
The HSJ Award for the ‘Best Pharmaceutical Partnership with the NHS was described by the organisers as ‘improving accurate, early diagnosis of Alzheimer’s Disease’.
The partnership is delivering work to improve early and more precise diagnosis of Alzheimer’s Disease, with an emphasis on developments in Mental Health Trusts. Dementias Platform UK and Lilly UK collaborated on this together with 4 NHS Trusts enrolled from the DPUK Trials Delivery Framework:
- Oxford Health NHS Foundation Trust
- Greater Manchester Mental Health Foundation Trust
- University Hospitals Sussex Foundation Trust
- Sheffield Teaching Hospital Foundation Trust.
It is an ambitious national collaborative pilot involving Lilly UK, Dementias Platform UK, and the NHS trusts, seeking to deliver earlier and more precise Alzheimer’s Disease diagnoses. Its further goal is to understand the costs and benefits in order to establish a framework for services across the NHS. Organisers believe that this transformative project has the potential to revolutionise the diagnostic landscape of AD in the UK, thereby improving outcomes for patients.
